世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033327

世界のポイントオブケア分子診断の市場規模調査・予測:用途別、技術別、エンドユーザー別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Point-of-Care Molecular Diagnostics Market Size study & Forecast, by Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), by Technology (PCR, Genetic Sequencing, Hybridization, and Microarray), by End-User (Hospitals, Homecare, and Other End-Users) and Regional Analysis, 2022-2029

発刊日 2022/10/08

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000033327

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のポイントオブケア(POC)分子診断市場は、2021年に約30億5,000万米ドルと評価され、予測期間の2022年から2029年には11.43%以上の健全な成長率で成長すると予想されています。

ポイントオブケア(POC)検査とは、患者に医療を提供する現場で検査を実施するタイプの検査です。ポイントオブケア(POC)分子診断市場は、慢性疾患の発生率の増加やポイントオブケア(POC)分子診断の需要増加などの要因によって拡大しています。

欧州疾病管理予防センターの2020年3月の報告によると、2018年にEUおよび欧州経済領域(EU/EEA)30カ国で新たに報告された結核患者は52,862人で、EU/EEAにおける報告率は10万人あたり10.2人、2018年の全結核診断例のうち、A DNA増幅試験、培養、塗抹によって36,047例が検証されています(ポリメラーゼ連鎖反応検査)。しかし、POC分子診断における高複合度の検査センターの不足と不透明な償還シナリオが市場成長を止める可能性があります。さらに、世界のポイントオブケア(POC)分子診断の市場は、製剤の進歩とR&Dセンターへの投資によって促進される可能性があると推測されます。

ポイントオブケア(POC)分子診断の世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、癌の有病率の上昇に起因する収益の面でスペースを支配しました。例えば国立がん研究所によると、癌患者の数は、2018年に1,810万例から、2040年までに、2,950万例に行ってきました。一方、アジア太平洋地域は、同地域における確立された企業の出現により、予測期間中に大きく成長することが期待されます。

主要企業

  • Meridian Bioscience Inc
  • Abbott Laboratories
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson, and Company
  • Danaher Corporation
  • BioMerieux
  • Agilent Technologies
  • OraSure Technologies Inc.
  • Thermo Fisher Scientific

調査対象の年

  • 実績データ - 2019年、2020年、2021年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2029年

この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

市場セグメント・サブセグメント

  • 技術別
    ➣ PCR
    ➣ 遺伝子配列決定
    ➣ ハイブリダイゼーション
    ➣ マイクロアレイ
  • 用途別
    ➣ 感染症
    ➣ 腫瘍学(オンコロジー)
    ➣ 血液学
    ➣ 出生前検査
    ➣ 内分泌学
    ➣ その他のアプリケーション
  • エンドユーザー別
    ➣ 病院
    ➣ ホームケア
    ➣ その他のエンドユーザー
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Point-of-Care Molecular Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Point-of-Care Molecular Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.3. Point-of-Care Molecular Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Point-of-Care Molecular Diagnostics Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Point-of-Care Molecular Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Point-of-Care Molecular Diagnostics Market Dynamics
3.1. Point-of-Care Molecular Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Rising Demand for Point-of-care Diagnostics
3.1.2. Market Challenges
3.1.2.1. A lack of high-complexity test centres in POC molecular testing
3.1.2.2. Uncertain reimbursement scenarios
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Investments in the R&D centre

Chapter 4. Global Point-of-Care Molecular Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Point-of-Care Molecular Diagnostics Market, by Application
6.1. Market Snapshot
6.2. Global Point-of-Care Molecular Diagnostics Market by Application, Performance - Potential Analysis
6.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
6.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Hematology
6.4.4. Endocrinology
6.4.5. Other Applications
6.4.6. Prenatal Testing

Chapter 7. Global Point-of-Care Molecular Diagnostics Market, by Technology
7.1. Market Snapshot
7.2. Global Point-of-Care Molecular Diagnostics Market by Technology, Performance - Potential Analysis
7.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
7.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Genetic Sequencing
7.4.3. Hybridization
7.4.4. Microarray

Chapter 8. Global Point-of-Care Molecular Diagnostics Market, by End-User
8.1. Market Snapshot
8.2. Global Point-of-Care Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by End-User, 2019-2029 (USD Billion)
8.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Homecare
8.4.3. Other End-Users

Chapter 9. Global Point-of-Care Molecular Diagnostics Market, Regional Analysis
9.1. Point-of-Care Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Point-of-Care Molecular Diagnostics Market
9.2.1. U.S. Point-of-Care Molecular Diagnostics Market
9.2.1.1. Application breakdown estimates & forecasts, 2019-2029
9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Point-of-Care Molecular Diagnostics Market
9.3. Europe Point-of-Care Molecular Diagnostics Market Snapshot
9.3.1. U.K. Point-of-Care Molecular Diagnostics Market
9.3.2. Germany Point-of-Care Molecular Diagnostics Market
9.3.3. France Point-of-Care Molecular Diagnostics Market
9.3.4. Spain Point-of-Care Molecular Diagnostics Market
9.3.5. Italy Point-of-Care Molecular Diagnostics Market
9.3.6. Rest of Europe Point-of-Care Molecular Diagnostics Market
9.4. Asia-Pacific Point-of-Care Molecular Diagnostics Market Snapshot
9.4.1. China Point-of-Care Molecular Diagnostics Market
9.4.2. India Point-of-Care Molecular Diagnostics Market
9.4.3. Japan Point-of-Care Molecular Diagnostics Market
9.4.4. Australia Point-of-Care Molecular Diagnostics Market
9.4.5. South Korea Point-of-Care Molecular Diagnostics Market
9.4.6. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market
9.5. Latin America Point-of-Care Molecular Diagnostics Market Snapshot
9.5.1. Brazil Point-of-Care Molecular Diagnostics Market
9.5.2. Mexico Point-of-Care Molecular Diagnostics Market
9.6. Rest of The World Point-of-Care Molecular Diagnostics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Meridian Bioscience Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Siemens Healthineers
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Becton, Dickinson, and Company
10.2.6. Danaher Corporation
10.2.7. BioMerieux
10.2.8. Agilent Technologies
10.2.9. OraSure Technologies Inc.
10.2.10. Thermo Fisher Scientific

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Point-of-Care Molecular Diagnostics Market, report scope
TABLE 2. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 4. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 5. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Point-of-Care Molecular Diagnostics Market, research methodology
FIG 2. Global Point-of-Care Molecular Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Point-of-Care Molecular Diagnostics Market, key trends 2021
FIG 5. Global Point-of-Care Molecular Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Point-of-Care Molecular Diagnostics Market, porters 5 force model
FIG 7. Global Point-of-Care Molecular Diagnostics Market, pest analysis
FIG 8. Global Point-of-Care Molecular Diagnostics Market, value chain analysis
FIG 9. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Point-of-Care Molecular Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Point-of-Care Molecular Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000033327

TOP